PCV59 PHARMACO-ECONOMIC ANALYSIS OF VALSARTAN/HYDROCHLOROTHIAZIDE (HCTZ)VERSUS CANDESARTAN/HCTZ AND VERSUS TELMISARTAN/HCTZ IN THE TREATMENT OF SYSTEMIC ARTERIAL HYPERTENSION IN MEXICO
Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67470-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)67470-0/fulltext
Section Title :
Section Order :
35
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67470-0&doi=10.1016/S1098-3015(10)67470-0